Stem Cell Therapy Market, by Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, and Others), by Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, and Others), and by Region (North

Stem Cell Therapy Market, by Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, and Others), by Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Stem cells are divided into two major classes; pluripotent and multipotent. Pluripotent stem cells are replicating cells, which are derived from the embryo or fetal tissues. The pluripotent stem cells facilitate the development of cells and tissues in three primary germ layers such as mesoderm, ectoderm, and endoderm.
Market Dynamics
Increasing expansion of facilities by market players for stem cell therapies is expected to propel growth of the stem cell therapy market over the forecast period. For instance, in January 2021, the University of Florida, U.S. launched the Center for Regenerative Medicine that is focused on development of stem cell therapies for the treatment of damaged tissue and organ. The Centre for Regenerative Medicines is divided into two segments such as focus groups and shared services. Focus groups such as research and development activities for stem cell therapies; and the shared services segment offers technical resources related to stem cell therapies.
Furthermore, rising collaboration activities by key players are expected to drive growth of the global stem cell therapy market. For instance, in May 2021, Procella Therapeutics and Smartwise, a medtech company entered into a collaboration with AstraZeneca Pharmaceuticals. Under this collaboration, AstraZeneca utilized Procella Therapeutics’ stem cell technology for the development of stem cell therapies in cardiovascular diseases. Moreover, in April, 2019, CelluGen Biotech and FamiCord Group collaborated to develop new stem cell-based drugs and advanced medical therapies (ATMP)
Key features of the study:
This report provides in-depth analysis of the stem cell therapy market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global stem cell therapy market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as part of this study include Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
The global stem cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the stem cell therapy market
Detailed Segmentation:
Global Stem Cell Therapy Market, By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
Global Stem Cell Therapy Market, By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
Global Stem Cell Therapy Market, By Region:
North America
By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
By Country:
U.S.
Canada
Latin America
By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Magellan*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Medipost Co., Ltd
Osiris Therapeutics, Inc.
Kolon TissueGene, Inc.
JCR Pharmaceuticals Co., Ltd.
Anterogen Co. Ltd.
Pharmicell Co., Inc.
Stemedica Cell Technologies, Inc.
“*” marked represents similar segmentation in other categories in the respective section.